XORTX Therapeutics (XRTX) announces the launch of a new late stage program to treat gout. The new drug development program – XRx-026 – will ...

XORTX to focus on late stage allopurinol intolerant gout program; discussion with FDA planned for first half 2025 regarding ...

You might just know someone, close or distant, who has struggled with drug addiction at one point in time. It could be a distant relative or someone you went to school with, but the sheer probability ...

Substance abuse in the United States is one of the leading health conditions impacting millions of lives and due to many types of drug addictions. Since 2000, there have been 700,000 overdose deaths ...

While there's no official recommendation for the most effective astragalus dosage, 9 to 30 grams per day is a typical dose. However, you should consult a doctor if you’re looking to use ...

The typical starting dosage ranges from 10 to 60 milligrams (mg) daily. Your doctor may adjust your dosage over the course of your treatment. The active ingredient in Prozac is fluoxetine.

Lauren Gray is a New York-based writer and editor with nearly a decade of experience covering health, wellness, ...

Vitamin D dosage recommendations can vary depending on several factors, including your age, skin color, medical history, and where you live. Vitamin D is commonly known as the “sunshine vitamin.” ...

Formularies also assign drugs to different tiers that determine what patients must pay out of pocket to access the drug. Generic drugs are typically placed in the tier with the lowest out-of ...

However, in some cases, the swelling may be significant and persistent. On rare occasions, an injected vaccine or drug can cause a potentially life-threatening, whole-body allergy known as anaphylaxis ...

Teen drug use continued to fall in 2024, extending a dramatic decline spurred by the COVID-19 pandemic that experts expected would reverse now that the acute phase of the global crisis is well over.

LONDON, Dec 17 (Reuters) - A new long-acting preventive HIV drug could reach the world’s poorest countries by the end of 2025 or early 2026, a global health official told Reuters on Tuesday.